Suchergebnisse - "De Jong, Menno D"

PubPharm (17)

1

Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19 : a substudy of the phase 2 PANAMO trial

enthalten in: Respiratory research | 2022

von Lim, E. | Vlaar, A. | Bos, L. | +81

2

Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection : a prospective cohort study

enthalten in: BMC medicine | 2022

von Verveen, A. | Wynberg, E. | van Willigen, H. | +53

3

Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study

enthalten in: BMC medicine | 2022

von Verveen, A. | Wynberg, E. | van Willigen, H. | +8

4

Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study

enthalten in: BMC medicine | 2022

von Verveen, A. | Wynberg, E. | van Willigen, H. | +8

5

Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron

enthalten in: Immunity | 2022

von van der Straten, K. | Guerra, D. | van Gils, M. | +24

6

The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC) : A prospective cohort study

enthalten in: Vaccine | 2022

von Wynberg, E. | Han, A. | Boyd, A. | +12

7

Clinical evaluation of single-swab sampling for rapid COVID-19 detection in outbreak settings in Dutch nursing homes

enthalten in: European geriatric medicine | 2022

von Paap, K. | van Loon, A. | Koene, F. | +5

8

Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021

enthalten in: Emerging infectious diseases | 2022

von Koopsen, J. | van Ewijk, C. | Bavalia, R. | +40

9

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

enthalten in: Cell reports. Medicine | 2022

von van Gils, M. | van Willigen, H. | Wynberg, E. | +77

10

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

enthalten in: eLife | 2021

von Grobben, M. | van der Straten, K. | Brouwer, P. | +42